LDLR and colorectal carcinoma: Although we did not find a direct causal effect of statin-targeted HMGCR on CRC risks, we confirmed that lipid-lowering LDLR variants, which are the key downstream genes in cholesterol metabolism, were associated with reduced CRC risks.